Skip to main content
Georgia Public Broadcasting Logo
  • TV

    Featured Specials and Programs

    • All Creatures Great and Small
    • Miss Scarlet & The Duke
    • Antiques Roadshow
    • PBS Newshour
    • Finding Your Roots
    • The U.S. and the Holocaust
    All Programs

    GPB Originals

    • Georgia Outdoors
    • View Finders
    • A Fork in the Road
    • The Steeple
    • Lawmakers
    • Football Fridays in Georgia
    GPB Originals

    Browse by Genre

    • Arts & Music
    • Culture
    • Drama
    • Food
    • History
    • News & Public Affairs
    • TV Schedule
    • GPB Programs
    • PBS Passport
    • TV Highlights this Week
    • PBS KIDS
    • Find Your Station
    • Newsletters
    • Contact GPB
  • Radio

    Featured Programs

    • Political Rewind
    • The Daily
    • Morning Edition
    • All Things Considered
    • Serendipity
    • John Lemley's City Cafe
    • Fresh Air
    • Here and Now
    • Code Switch/Life Kit
    • Wait Wait... Don't Tell Me!
    All Programs

    Podcasts

    • GA Today
    • Salvation South
    • Battleground: Ballot Box
    • Football Fridays in Georgia
    • Classroom Conversations
    • Radio Schedule
    • GPB Classical
    • Radio Programs
    • Podcasts
    • GPB News
    • Find Your Station
    • Contact GPB
    • Newsletters
  • News

    Featured Programs & Series

    • Political Rewind
    • Lawmakers
    • Lawmakers: Beyond the Dome
    • 1A
    • Battleground: Ballot Box
    • What You Need to Know: Coronavirus
    • Southern Reading List
    • Powering Georgia
    • Food Access

    More GPB News

    • Politics
    • Georgia News
    • Justice
    • Arts & Life
    • Health
    All GPB News
    • Radio Schedule
    • Radio Stations
    • GPB Apps
    • Contact GPB News
    • Follow Us on Apple News
    • Newsletters
  • Education

    Browse by Subject

    • CTAE
    • English Language Arts
    • Mathematics
    • Physical Health and Wellness
    • Professional Learning
    • STEAM
    • Science
    • Social Studies
    • The Arts
    • World Languages

    Browse by Grade

    • Preschool-PreK
    • K-2
    • 3-5
    • 6-8
    • 9-12

    Featured

    • Classroom Conversations Podcast
    • Georgia Studies Collection
    • Econ Express
    • VR in the Classroom
    • Lights, Camera, Budget!
    • Georgia Home Classroom
    • Chemistry Matters
    • Physics in Motion
    • Virtual Field Trips
    • Writers Contest
    • PBS LearningMedia
    • PBS KIDS
  • Sports
  • Events

    Browse by Type

    • Community
    • Donor
    • Kids & Family
    • Screenings
    All Events

    Browse by Category

    • Education
    • News
    • Sports
    • Television

    Sign up to receive GPB Event announcements via Email.

    Sign up

    • on Twitter
    • on Facebook
    • on Instagram
  • Kids & Family

    For Kids

    • Video
    • Games

    For Parents & Caregivers

    • Kids & Family Blog
    • Kids & Family Events
  • Support Us

    Support GPB

    • Ways to Give
    • Planned Giving
    • Sustainers
    • GPB Passport
    • Leadership Giving
    • Corporate Sponsorship
    • Vehicle Donations
    • GPB Next
    • Matching Gifts
  • Search
GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Listen Live Listen Live Watch Live Watch Live
GPB News

GPB Newsletter CTA

Sign Up For Our Newsletter

News Topics

  • Georgia
  • National
  • Election
  • Lawmakers
  • Battleground: Ballot Box

Don't Miss

Don't Miss:

  • Watch: GPB's Lawmakers
  • TV Highlights This Week
  • GA Today daily podcast

News Articles: Alzheimer's Disease

U.S. health officials approved Leqembi, a new Alzheimer's drug that modestly slows the brain disease. The FDA granted accelerated approval Friday for patients in early stages of Alzheimer's.

Tagged as: 

  • Science

FDA approves Alzheimer's drug that appears to modestly slow disease

An Alzheimer's drug that removes the substance amyloid from the brain has received a conditional approval from the FDA. A large study found the drug decreased the loss of thinking and memory by 27%.

January 07, 2023
|
By:
  • Jon Hamilton

Tagged as: 

  • News

Georgia Today: Recycling your tree, positive news for Alzheimer's patients, the Savannah Bananas

On the Monday Dec. 26 edition of Georgia Today: Where to recycle your Christmas tree, positive news for Alzheimer's patients, a look at the Savannah Bananas.

December 26, 2022
|
By:
  • Peter Biello and
  • Jeremy Powell
This illustration made available by the National Institute on Aging/National Institutes of Health depicts cells in an Alzheimer's-affected brain. An experimental drug modestly slowed the brain disease's progression, researchers reported Tuesday.

Tagged as: 

  • Science

Study: Alzheimer's drug shows modest success slowing declines in memory, thinking

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

November 30, 2022
|
By:
  • Jon Hamilton
A doctor points to PET scan results that are part of Alzheimer's disease research. Much work in the field focuses a substance called beta-amyloid. A new study could test whether that's the right target.

Tagged as: 

  • Science

What causes Alzheimer's? Study puts leading theory to 'ultimate test'

Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease.

November 02, 2022
|
By:
  • Jon Hamilton
Medical Minute

Tagged as: 

  • Medical Treatments

Medical Minute: Alzheimer's Microvascular Disease

This week’s Medical Minute, discusses the role of microvascular disease in the progression of Alzheimer’s.

August 20, 2022
|
By:
  • GPB News Staff
More than 1,000 people age 50 or older took one of four versions of the SAGE test.

Tagged as: 

  • Health

Is reversing early-stage Alzheimer’s disease possible? A new study finds it may be

Rather than treating patients in clinical trials with a specific drug, doctors are taking a more personalized approach by attempting to understand root causes of and the best treatments for diseases affecting cognitive decline, such as Alzheimer’s. 

July 11, 2022
|
By:
  • Ellen Eldridge

Tagged as: 

  • Science

This form of memory loss is common — but most Americans don't know about it

Mild cognitive impairment, a common brain condition, can be an early sign of Alzheimer's disease. But most people don't know the symptoms. And some may mistake it for normal aging.

March 18, 2022
|
By:
  • Jon Hamilton
Amy Bloom and Brian Ameche married in 2007. He was diagnosed with Alzheimer's disease in 2019.

Tagged as: 

  • On Aging

After an Alzheimer's diagnosis, her husband asked for help to die with dignity

Novelist Amy Bloom talks about how, at her husband's insistence, she traveled with him to Zurich so he could legally terminate his life. Her new memoir is In Love.

March 08, 2022
|
By:
  • Terry Gross
GPB News NPR

Tagged as: 

  • Science

Art and music therapy seem to help with brain disorders. Scientists want to know why

Arts therapies appear to ease brain disorders from Parkinson's to PTSD. Now, artists and scientists have launched an effort to understand how these treatments change the brain.

February 19, 2022
|
By:
  • Jon Hamilton
Microglia, specialized cells like the one seen in the center of this image, can restrain the accumulation of beta-amyloid protein (plaques in orange) that are a hallmark of Alzheimer's disease. But the cells sometimes contribute to the progression of the illness, researchers say.

Tagged as: 

  • Health

How a hyperactive cell in the brain might trigger Alzheimer's disease

Microglia are amoeba-like cells that scour the brain for injuries and invaders. But sometimes the usually helpful cells go into overdrive and damage the brain, researchers say.

January 31, 2022
|
By:
  • Bret Stetka
Scientists at the Allen Institute for Brain Science uncovered differences among human brain cells (left) those of the marmoset monkey (middle) and mouse in a brain region that controls movement, the primary motor cortex.

Tagged as: 

  • Science

New brain maps could help the search for Alzheimer's treatments

Scientists have created detailed maps of the brain area that controls movement in mice, monkeys and people. The maps could help explain human ailments like Alzheimer's and Lou Gehrig's disease.

October 06, 2021
|
By:
  • Jon Hamilton
Dr. Wendy Bollag and Dr. Carlos Isales

Tagged as: 

  • Health

Medical College Of Georgia Program Seeks To Inspire Doctors For The Elderly As Population Ages

By 2034, there will be 77 million people age 65 years and older compared to 76.5 million under the age of 18, according to the U.S. Census Bureau. There are roughly 7,300 geriatricians practicing in the United States and the American Geriatrics Society expects 30,000 geriatricians will be needed by 2030.

August 09, 2021
|
By:
  • Ellen Eldridge
As part of a clinical study, a patient with Alzheimer's disease receives an infusion of aducanumab at a Providence, R.I., hospital in 2019. Aducanumab is being marketed as Aduhelm.

Tagged as: 

  • Health

A New Alzheimer's Drug Comes With Lots Of Questions About How To Use It

Weeks after the Food and Drug Administration approved the Alzheimer's drug Aduhelm, doctors are struggling to figure out who should get the drug and how to use it safely.

July 29, 2021
|
By:
  • Jon Hamilton
Dr. Allan Levey stands in the doorway of an office.

Tagged as: 

  • Health

Emory's New Institute Brings Personalized Medicine To Dementia, Brain Diseases

Researchers at Emory University's Brain Health Center hope to better understand the root causes of dementia diseases such as Alzheimer's and mental health disorders such as depression by examining individual patients' biological, medical and lifestyle factors.

Dr. Allan Levey is leading the Brain Health Personalized Medicine Institute at Emory University.

June 07, 2021
|
By:
  • Ellen Eldridge
Dr. William Burke reviews a PET brain scan at Banner Alzheimer's Institute in Phoenix in 2018. An experimental Alzheimer's drug from Biogen and Eisai is on the verge of a Food and Drug Administration decision.

Tagged as: 

  • Health

FDA Poised For Decision On Controversial Alzheimer's Drug

The FDA has until Monday to decide whether to approve the first new Alzheimer's drug in nearly two decades. Two big studies of the drug produced conflicting results.

June 04, 2021
|
By:
  • Jon Hamilton
  • Load More

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News

Footer

Footer First Nav (Main Menu)

  • TV
  • Radio
  • News
  • Education
  • Sports
  • Events
  • Kids & Family
  • Support Us
  • Search

Footer Second Nav Menu

  • Help Center
  • About GPB
  • Contact Us
  • Closed Captioning
  • Directions
  • Studio Production
  • Program Submissions

Footer Third Nav Menu

  • Support Us
  • Careers
  • Accessibility
  • FCC Public Files
  • Drawing Rules
  • News Media Request
  • Open Records Policy
  • Privacy Policy

Georgia Public Broadcasting

260 14th St. NW
Atlanta, GA 30318
United States

(404) 685-2400 In Atlanta
(800) 222-4788 Outside Atlanta
ask@gpb.org

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News
© Copyright 2023, Georgia Public Broadcasting. All Rights Reserved. Georgia Public Radio® GPTV®